BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM

Buprenorphine and Naloxone
$1.3139per EA
DEA Schedule CIII

Strength

2; .5 mg/1; mg/1

Manufacturer

Alvogen Inc.

NDC

47781035503

Classification

Generic

Dosage Form

FILM

Route

BUCCAL; SUBLINGUAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205954

On Market Since

2/11/2019

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price History

1W

0.0%

1M

+1.5%

3M

-1.4%

6M

-31.3%

1Y

-30.3%

3Y

-42.2%

5Y

-48.6%

All

-59.5%